Cytodyn, Inc.

This study aimed to provide continued access to a weekly injection called PRO140 for HIV patients who had successfully completed an earlier trial and were benefiting from the treatment. The research followed 43 treatment-experienced patients to monitor how well the injection kept…

This study tested whether adding an experimental drug called leronlimab to standard chemotherapy (carboplatin) could help control advanced triple-negative breast cancer that had a specific marker (CCR5+). The first part aimed to find a safe dose, and the second part planned to se…

This study aimed to see if people with well-controlled HIV could maintain viral suppression using just a weekly PRO140 injection, instead of their usual daily pill regimen. It was an extension study for 56 participants who had already successfully completed 48 weeks of a previous…

This extension study tested whether weekly PRO140 injections alone could maintain HIV suppression long-term in people who successfully switched from standard combination therapy. The trial enrolled 20 adults who had already completed 12 weeks of PRO140 treatment without their vir…